Cargando…

DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas

Latent Epstein-Barr virus (EBV) infection is associated with several types of cancer. Several clinical studies have targeted EBV antigens as immune therapeutic targets with limited efficacy of EBV malignancies, suggesting that additional targets might be important. BamHI-A rightward frame 1 (BARF1)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Xizhou, Perales-Puchalt, Alfredo, Wojtak, Krzysztof, Xu, Ziyang, Yun, Kun, Bhojnagarwala, Pratik S., Bordoloi, Devivasha, Park, Daniel H., Liaw, Kevin, Bah, Mamadou A., Lieberman, Paul M., Gary, Ebony N., Patel, Ami, Weiner, David B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761958/ https://www.ncbi.nlm.nih.gov/pubmed/35071745 http://dx.doi.org/10.1016/j.omto.2021.12.017

Ejemplares similares

Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein–Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth
por: Wojtak, Krzysztof, et al.
Publicado: (2019)

Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escape
por: Park, Daniel H., et al.
Publicado: (2023)

A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy
por: Bordoloi, Devivasha, et al.
Publicado: (2022)

Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers
por: Bordoloi, Devivasha, et al.
Publicado: (2023)

In vivo DNA-launched bispecific T cell engager targeting IL-13Rα2 controls tumor growth in an animal model of glioblastoma multiforme
por: Bhojnagarwala, Pratik S., et al.
Publicado: (2022)

A synDNA vaccine delivering neoAg collections controls heterogenous, multifocal murine lung and ovarian tumors via robust T cell generation
por: Bhojnagarwala, Pratik S., et al.
Publicado: (2021)

The Methylation Status and Expression of Epstein-Barr Virus Early Genes BARF1 and BHRF1 in Epstein-Barr Virus-Associated Gastric Carcinomas
por: Li, Jing, et al.
Publicado: (2017)

Secretion of Epstein-Barr Virus-encoded BARF1 oncoprotein from latently infected B cells
por: Fiorini, Sylvie, et al.
Publicado: (2008)

Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma
por: Hutajulu, Susanna H, et al.
Publicado: (2010)

Recent Advances on the Possible Neuroprotective Activities of Epstein-Barr Virus Oncogene BARF1 Protein in Chronic Inflammatory Disorders of Central Nervous System
por: Wynne, Alicia, et al.
Publicado: (2010)

Sequence analysis of Epstein-Barr virus (EBV) early genes BARF1 and BHRF1 in NK/T cell lymphoma from Northern China
por: Sun, Lingling, et al.
Publicado: (2015)

Epstein–Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ΔNp63α in Undifferentiated Nasopharyngeal Carcinoma
por: Hoebe, Eveline, et al.
Publicado: (2018)

Immunotherapy of prostate cancer using novel synthetic DNA vaccines targeting multiple tumor antigens
por: Bordoloi, Devivasha, et al.
Publicado: (2021)

Epstein-Barr virus BARF1-induced NFκB/miR-146a/SMAD4 alterations in stomach cancer cells
por: Kim, Dong Ha, et al.
Publicado: (2016)

Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity
por: Choi, Hyeree, et al.
Publicado: (2021)

Synthetic DNA Delivery of an Engineered Arginase Enzyme Can Modulate Specific Immunity In Vivo
por: Khoshnejad, Makan, et al.
Publicado: (2020)

Combination of the LEP II f \barf Results
por: LEPEWWG ff Subgroup
Publicado: (2018)

Epstein–Barr virus and multiple sclerosis
por: Soldan, Samantha S., et al.
Publicado: (2022)

MAPK/c-Jun signaling pathway contributes to the upregulation of the anti-apoptotic proteins Bcl-2 and Bcl-xL induced by Epstein-Barr virus-encoded BARF1 in gastric carcinoma cells
por: Zhang, Yuqiong, et al.
Publicado: (2018)

The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies
por: Lo, Angela Kwok-Fung, et al.
Publicado: (2020)

Synthetic DNA delivery by electroporation promotes robust in vivo sulfation of broadly neutralizing anti-HIV immunoadhesin eCD4-Ig
por: Xu, Ziyang, et al.
Publicado: (2018)

Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein
por: Bordoloi, Devivasha, et al.
Publicado: (2021)

Correction to: In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies
por: Patel, Ami, et al.
Publicado: (2020)

In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies
por: Patel, Ami, et al.
Publicado: (2020)

IL-33 delays metastatic peritoneal cancer progression inducing an allergic microenvironment
por: Perales-Puchalt, Alfredo, et al.
Publicado: (2018)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Kidney involvement of chronic active Epstein‐Barr virus infection
por: Fukumoto, Ami, et al.
Publicado: (2023)

Interpreting the Epstein-Barr Virus (EBV) Epigenome Using High-Throughput Data
por: Arvey, Aaron, et al.
Publicado: (2013)

Simplifying checkpoint inhibitor delivery through in vivo generation of synthetic DNA-encoded monoclonal antibodies (DMAbs)
por: Perales-Puchalt, Alfredo, et al.
Publicado: (2019)

Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing
por: Mahalingam, Sundarasamy, et al.
Publicado: (2021)

Selection of the Channel e^+e^- -> H^0Z0-> f\barf\mu^+\mu^-
por: de Deboeck, H, et al.
Publicado: (1989)

The Batrachian Barf Bowl: An authentic research experience using ecological data from frog diets
por: Larson, Joanna G., et al.
Publicado: (2022)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mni8u2hov8iebad3eln2mdqhgr